Physician profile
Timothy Murray
NPI 1891744249
$9,302.30
in general payments reported to CMS, 2019-2025
15 companies · $17.85 in 2025
The $17.85 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,843 · 2021: $118 · 2022: $96.79 · 2023: $75.65 · 2024: $151 · 2025: $17.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $244.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,748.77 | 2019-2024 | |
| Acera Surgical, INC. | $102.70 | 2019 | |
| Axonics, INC. | $67.43 | 2023-2024 | Axonics |
| Kowa Pharmaceuticals America, INC. | $54.41 | 2022-2023 | Seglentis, Livalo |
| Davol INC. | $53.78 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $53.49 | 2021-2022 | |
| Medtronic, INC. | $44.74 | 2023-2024 | Interstim, Parietene Ds |
| Ethicon US, LLC | $36.55 | 2019-2021 | |
| Abbvie INC. | $28.82 | 2024 | |
| Trevena, INC. | $21.68 | 2021 | |
| Tela Bio, INC. | $21.09 | 2022 | |
| Braintree Laboratories, INC. | $19.85 | 2024 | Suflave, Sutab |
| Teva Pharmaceuticals USA, INC. | $19.22 | 2024 | Austedo Xr |
| Boston Scientific Corporation | $17.85 | 2025 | Axonics |
| La Jolla Pharmaceutical Company | $11.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.